Despite the continued success of GLP-1 drugs Ozempic and Wegovy, Novo Nordisk CEO Lars Fruergaard Jørgensen took a slight pay cut in 2024. He received 57.1 million Danish kroner (DKK) – $8 million – ...
Short-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling ...
A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms ...
A child in West Texas has died of measles, state health officials said on Wednesday (February 26), the first reported U.S.
The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.
The results showed statistically significant and clinically meaningful improvement in progression-free survival compared with ...